(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT)
`
`
`
`
`
`
` a
`
`(19) World Intellectual Property Organization
`International Bureau
`
`(10) International Publication Number
`(43) International Publication Date
`WO 2011/085075 A2
`14 July 2011 (14.07.2011)
`
`
`(1) International Patent Classification:
`C1I2N 15/10 (2006.01)
`.
`sue
`:
`(21) International Application Numer:rUS>01 1020335
`oe
`(22) International Filing Date:
`
`_
`(25) Filing Language:
`(6) Publication Language:
`
`6 January 2011 (06.01.2011)
`.
`English
`Fnglish
`
`(81) Designated States (unless otherwise indicated, for every
`kind ofnational protection available): AE, AG, AL, AM,
`AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ,
`CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO,
`DZ, EC, EE, EG, ES, FL GB, GD, GE, GH, GM, GT,
`HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP,
`KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD,
`ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NL
`NO, NZ, OM,PE, PG, PH, PL, PT, RO, RS, RU,SC, SD,
`SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR,
`TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
`.
`en
`(84) Designated States (unless otherwise indicated, for every
`kind ofregional protection available): ARIPO (BW, GH,
`GM, KE, LR, LS, MW, MZ, NA,SD, SL, SZ, TZ, UG,
`ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU,TJ,
`TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK,
`(71) Applicant (for all designated States except US): GENY,
`EE, ES, FL, FR, GB, GR, HR, HU,IE, IS, IT, LT, LU,
`INC. [US/US]; 500 Technology Square, Suite 130, Cam-
`LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SL SK,
`bridge, Massachusetts 02139 (US).
`SM, TR), OAPI (BF, BJ, CF, CG, CL CM, GA, GN, GQ,
`Inventors; and
`GW, ML, MR,NE, SN, TD, TG).
`JACOBSON,
`(for US only):
`Inventors/Applicants
`Joseph [US/US]; 223 Grant Avenue, Newton, Mas- Published:
`Sachusetts024°OS).waeaayjivang[ONUSE —_without international search report and to be republished
`02139 (US)
`>
`>
`Se
`-
`upon receipt ofthat report (Rule 48.2(g))
`(74) Agent: | CAMACHO,
`Jennifer A.; Greenberg Traurig — with sequence listingpart ofdescription (Rule 5.2(a))
`*
`nd
`>
`LLP, One International Place, Boston, Massachusetts
`02110(US).
`
`GO) Priority Data:
`61/293.192
`61/310.076
`61/334,416
`
`7 January 2010 (07.01.2010)
`3 March 2010 (03.03.2010)
`13 May 2010 (13.05.2010)
`
`us
`US
`US
`
`(72)
`(75)
`
`’
`
`(54) Title: ASSEMBLY OF HIGH FIDELITY POLYNUCLEOTIDES
`
`(57) Abstract: Mcthods and apparatus relate to the synthesis of high fidclity polynucleotides and to the reduction of sequencecr-
`tors generated during synthesis of nucleic acids on a solid support. Specifically, design of support-bound template oligonu-
`cleotides is disclosed. Assembly methods include cycles of annealing, stringent wash and extension of polynucleotides comprising
`a sequence region complementary to immobilized template oligonucleotides. The error free synthetic nucleic acids generated
`therefrom can be used for a variety of applications, including synthesis of biofuels and value-added pharmaceutical products.
`
`
`
`
`
`wo2011/085075A2!ANTIAIUMDIMTAIANAAANTAAAT
`
`

`

`WO 2011/085075
`
`PCT/US2011/020335
`
`ASSEMBLYOF HIGH FIDELITY POLYNUCLEOTIDES
`
`RELATED APPLICATIONS
`
`[0001] This application claims the benefit of U.S. Provisional Patent Application Ser. No.
`
`61/293,192, filed January 07, 2010; U.S. Provisional Patent Application Ser. No. 61/310,076,
`
`filed March 03, 2010; and U.S. Provisional Patent Application Ser. No. 61/334,416, filed May
`
`13, 2010, cach of which is incorporated herein by referencein its entircty.
`
`FIELD OF THE INVENTION
`
`[0002] Methods and apparatuses provided herein relate to the synthesis and assembly of high
`
`fidelity nucleic acids and nucleic acid libraries having a predefined sequence. Moreparticularly,
`
`methods and apparatuses are provided for polynucleotide synthesis, error reduction, and/or
`
`sequence verification on a solid support.
`
`In some embodiments, picoliter and sub-picoliter
`
`dispensing and droplet moving technologies are applied to access and manipulate the
`
`oligonucleotides on DNA microarrays.
`
`BACKGROUND
`
`[0003] Using the techniques of recombinant DNA chemistry,
`
`it is now common for DNA
`
`sequences to be replicated and amplified from nature and then disassembled into component
`
`parts. As component parts, the sequences are then recombined or reassembled into new DNA
`
`sequences.
`
`However,
`
`reliance on naturally available sequences significantly limits the
`
`possibilities that may be explored by researchers. While it is now possible for short DNA
`
`sequences to be directly synthesized from individual nucleosides,
`
`it has been generally
`
`impractical
`
`to directly construct
`
`large segments or assemblies of polynucleotides, 1.c.,
`
`polynucleotide sequences longer than about 400 basepairs.
`
`[0004] Oligonucleotide synthesis can be performed through massively parallel custom syntheses
`
`on microchips (Zhou et al. (2004) Nucleic Acids Res. 32:5409; Fodor et al. (1991) Science
`
`251:767). However, current microchips have very low surface areas and hence only small
`
`amounts of oligonucleotides can be produced. When released into solution, the oligonucleotides
`
`are present at picomolar or
`
`lower concentrations per sequence, concentrations that are
`
`insufficiently high to drive bimolecular priming reactions efficiently. Current methods for
`
`assembling small numbers of variant nucleic acids cannot be scaled up in a cost-effective manner
`
`-l-
`
`

`

`WO 2011/085075
`
`PCT/US2011/020335
`
`to generate large numbers of specified variants. As such, a need remains for improved methods
`
`and devices for high-fidelity gene assembly andthe like.
`
`[0005] Furthermore, oligonucleotides on microchips are generally synthesized via chemical
`
`reactions. Spurious chemical reactions cause random baseerrors in oligonucleotides. One of the
`
`critical
`
`limitations in chemical nucleic acid synthesis is the error-rate. The error rate of
`
`chemically-synthesized oligonucleotides (e.g. deletions at a rate of 1
`
`in 100 bases and
`
`mismatches and inscrtions at about |
`
`in 400 bascs) cxeeeds the crror rate obtainable through
`
`enzymatic means of replicating an existing nucleic acid (e.g., PCR). Therefore, there is an
`
`urgent need for new technology to produce high-fidelity polynucleotides.
`
`SUMMARY
`
`[0006] Aspects of the invention relate to methods and apparatuses for preparing and/or
`
`assembling high fidelity polymers. Also provided herein are devices and methods for processing
`
`nucleic acid assembly reactions and assembling nucleic acids.
`
`It is an object of this invention to
`
`provide practical, economical methods of synthesizing custom polynucleotides.
`
`It is a further
`
`object to provide methods of producing synthetic polynucleotides that have lowererror rates than
`
`synthetic polynucleotides made by methods knowninthe art.
`
`[0007] According to one embodiment,
`
`the invention provides a method for producing a
`
`polynucleotide having a predetermined sequence on a solid support.
`
`In some embodiments,
`
`pluralities of support-boundsingle-stranded oligonucleotides are provided at different features of
`
`a solid support, each plurality of oligonucleotides having a predefined sequence and each
`
`plurality being bound to a different discrete feature of the support.
`
`In some embodiments, each
`
`plurality of oligonucleotides comprises a sequence region at its 5’ end that is the same as a
`
`sequence region of a 3’ end of another oligonucleotide and a sequence region at its 3’ end that is
`
`the same as a sequence region at a 5’ end of a different oligonucleotide and wherein the first
`
`plurality of oligonucleotides has a 3’ end that is complementary to a 3’ end ofa first input single-
`
`stranded oligonucleotide.
`
`In some embodiments, the first plurality of oligonucleotide comprises
`
`at its 5’ cnd a scquence region that is the same as a scquence region at the 3’ end of a second
`
`oligonucleotide and the Nth plurality of oligonucleotide comprisesat its 3’ end a sequence region
`
`that is the same as a sequence region of the (N-1) oligonucleotide.
`
`In some embodiments, a first
`
`input oligonucleotide is provided in solution at
`
`the feature where the first plurality of
`
`

`

`WO 2011/085075
`
`PCT/US2011/020335
`
`oligonucleotides is immobilized. A first plurality of complementary oligonucleotides is
`
`synthesized by template-dependent synthesis in which each ofthe first plurality of support-bound
`
`oligonucleotides is hybridized with the first input oligonucleotide thereby forming an extension
`
`product duplex. The extension product duplex is dissociated to release the first plurality of
`
`complementary oligonucleotides. The first plurality of complementary oligonucleotides (e.g.,
`
`second input oligonucleotide) may then anneal to a second plurality of support-bound single
`
`stranded oligonucleotides wherein the anncaling of the first plurality of complementary
`
`oligonucleotides to the second plurality of support-bound oligonucleotides serves as a primer for
`
`extension of the first plurality of complementary oligonucleotides. The cycles of primer
`
`extension, dissociation and annealing can be repeated until
`
`the target polynucleotide is
`
`synthesized. The target polynucleotide can be amplified.
`
`In some embodiments,the first input
`
`oligonucleotide is a primer, for example a universal primer or a unique primer.
`
`In other
`
`embodiments, the first input oligonucleotide is a synthetic oligonucleotide or a single stranded
`
`nucleic acid fragment. The plurality of support bound oligonucleotides may be synthesized on
`
`the solid support or synthetic oligonucleotides can be spotted on the solid support.
`
`In some
`
`embodiments, the solid support is a microarray device.
`
`[0008] Some aspects of the invention relates to a method for producing at
`
`least one
`
`polynucleotide having a predefined sequence, the method comprising providing at least a first
`
`and a second plurality of support-bound single-stranded oligonucleotides, wherein each first and
`
`secondplurality of oligonucleotides has a predefined sequence and is boundto a discrete feature
`
`of the support, each first plurality of oligonucleotides comprising a sequence region at its 5’ end
`
`that is the same as a sequence region of a 3’ end of the second plurality of oligonucleotides. A
`
`plurality of first input single-stranded oligonucleotides is provided wherein the 3’ end of the
`
`plurality of the first input oligonucleotide is complementary to the 3’ end ofthe first plurality of
`
`oligonucleotides. The plurality of first input oligonucleotides is hybridized to the first plurality
`
`of support-bound oligonucleotides at a first feature and a first plurality of complementary
`
`oligonucleotides is generated in a chain extension reaction, thereby forming an extension product
`
`duplex. The extension product duplex is dissociated, thereby producing a first plurality of
`
`complementary oligonucleotides. The first plurality of complementary oligonucleotides is
`
`transferred from the first feature to a second feature, thereby bringing into contact the first
`
`plurality of complementary oligonucleotides
`
`to the second plurality of support-bound
`
`-3-
`
`

`

`WO 2011/085075
`
`PCT/US2011/020335
`
`oligonucleotides. The first plurality of complementary oligonucleotides is then annealed to the
`
`second plurality of support-bound single stranded oligonucleotides at the second feature, wherein
`
`the annealing of the first plurality of complementary oligonucleotides to the second plurality of
`
`support-bound oligonucleotides serves as a primer for extension of the first plurality of
`
`complementary oligonucleotides, thereby producing the polynucleotide.
`
`[0009] In some embodiments, a third plurality of support-bound single-stranded oligonucleotides
`
`is provided wherein cach third plurality of oligonuclcotidcs has a predefined scquence and is
`
`bound to a third discrete feature of the support, each third plurality of oligonucleotides
`
`comprising a sequence region at its 3’ end that is the same as a sequence region of a 5’ end of the
`
`second plurality of oligonucleotides, and repeating annealing, chain extension, denaturation and
`
`transferring steps to produce a longer polynucleotide.
`
`[0010] In some aspects of the invention, the reaction steps are performed within discrete droplet
`
`volumes (nanoliter, picoliter or subpicoliter droplets volumes).
`
`In some embodiments, the
`
`annealing and extension steps are performed within a first droplet volume at a first feature and
`
`the first plurality of complementary oligonucleotides is released within the first droplet volume.
`
`The first droplet volume may be moved to a second feature comprising a second plurality of
`
`support-bound oligonucleotides. Droplets volumes may be moved at specific locations of the
`
`solid support by different
`
`techniques such as electrowetting or following a hydrophilicity
`
`gradient.
`
`In some embodiments,
`
`the whole support
`
`is subjected to conditions promoting
`
`annealing or primer extension or denaturing. In some embodiments,
`
`the whole support or
`
`selected features are subjected to thermocycling conditions. In other embodiments, selected
`
`features are subjected to conditions promoting annealing or primer extension or denaturing.
`
`[0011] Aspects of the invention relate to the synthesis of at
`
`least one high fidelity target
`
`polynucleotide having a predetermined sequence.
`
`In some embodiments, the method comprises
`
`the steps of providing pluralities of different support-bound single-stranded oligonucleotides at
`
`different features of a solid support, wherein each plurality of support-bound oligonucleotides
`
`has at least two sequence regions, a first sequence region at its 5’ end that is the same as a
`
`sequence region of the 3’ end of another oligonucleotide and a second sequence regionatits 3’
`
`end that is the same as a sequenceregion at a 5’ end of a different oligonucleotide and wherein
`
`each plurality of oligonucleotides has a 3° end that is complementary to a 3’ end of a different
`
`input single-stranded polynucleotide. A first input polynucleotide is provided in solution at the
`
`-4-
`
`

`

`WO 2011/085075
`
`PCT/US2011/020335
`
`feature of a first plurality of support-bound oligonucleotides wherein the input polynucleotide 1s
`
`generated from a previous extension step. Thefirst input polynucleotide is hybridized to the first
`
`plurality of support-bound oligonucleotides under hybridizing conditions thereby forming
`
`duplexes.
`
`In some embodiments, the duplexes may comprise duplexes having at least one
`
`mismatch in a complementary region and/or duplexes that do not comprise a mismatch in the
`
`complementary region. The duplexes having at least one mismatch in the complementary region
`
`are unstable duplexes that can be denatured understringent melt conditions. The stringent melt
`
`conditions (e.g., stringent melt temperature) do not denature the duplexes that do not comprise a
`
`mismatch
`
`in
`
`the
`
`complementary region
`
`(stable
`
`duplexes).
`
`Error-containing input
`
`polynucleotides are then released in solution and removed. The remaining stable duplexes can
`
`then be subjected to primer extension conditions, generating a first plurality of complementary
`
`oligonucleotides by template-dependent synthesis, thereby forming an extension product duplex.
`
`The extension product duplex is dissociated to release a second input polynucleotide (or
`
`complementary polynucleotide). The second input polynucleotide can be allowed to anneal to a
`
`second plurality of support-bound single stranded oligonucleotides. Cycles of stringent melt,
`
`extension, dissociation and annealing are repeated until the target polynucleotide is synthesized.
`
`[0012] In some embodiments, the annealing and stringent melt steps can be performed within a
`
`first droplet volumeat a first feature thereby releasing the error-containing polynucleotides in the
`
`first droplet volume. The first droplet volume can be discarded and a second droplet volume
`
`comprising reagent for primer extension can be added to the first feature under condition
`
`promoting primer extension. Complementary strands are released into the second droplet volume
`
`and the second droplet volume may be movedto a second feature comprising a secondplurality
`
`of support bound oligonucleotides.
`
`In some embodiments, the support-bound oligonucleotides
`
`comprise a third sequence region at the 3’ end of the oligonucleotide. In some embodiments, the
`
`plurality of different support-bound single-stranded oligonucleotides at different features of a
`
`solid support comprises at least three sequence regions: a 5° end sequence region N,at least two
`
`sequence regions (N-1) and (N-2)
`
`that are complementary to the 3’ end of an input
`
`polynucleotide, and a 3’ end sequence region. The (N-1) sequence region is adjacent to the 5’
`
`end sequence region and the (N-2) sequenceregion is adjacent to the (N-1) sequence region.
`
`In
`
`some embodiments, a first input polynucleotide is provided in solution at the feature of a first
`
`plurality of support-bound oligonucleotides wherein the first input polynucleotide comprises
`
`-5-
`
`

`

`WO 2011/085075
`
`PCT/US2011/020335
`
`sequences regions complementary to the at least two sequences regions (N-1) and (N-2). The
`
`first input polynucleotide is hybridized with the first plurality of support-bound oligonucleotides
`
`under hybridizing conditions wherein the 3’ end of the first input polynucleotide hybridizes, at
`
`least in part, to the at least two sequence regions (N-1) and (N-2) of the oligonucleotides thereby
`
`forming duplexes,
`
`the duplexes comprising a first duplex having at least one mismatch in a
`
`complementary region and a second duplex that does not comprise a mismatch in the
`
`complementary region. The first duplex may be denatured under stringent melt conditions
`
`without denaturing the second duplex.
`
`In this fashion, error-contaming input polynucleotides are
`
`released in solution and may be removed.
`
`In subsequentstep, a first plurality of complementary
`
`oligonucleotides is generated by template-dependent synthesis under condition promoting
`
`extension of the input polynucleotides thereby forming an extension product duplex. The
`
`extension product is dissociated, releasing a second input polynucleotide. The second input
`
`
`
`polynucleotide may anneal support-bound—single-strandedto a second plurality of
`
`
`
`
`
`
`
`oligonucleotides and by repeating the cycles of stringent melt, extension, dissociation and
`
`annealing, the target polynucleotide is synthesized.
`
`[0013] Aspects of the invention relate to a method of removing error-containing polynucleotides
`
`synthesized on a solid support, the method comprising the following steps. A plurality of
`
`support-bound single
`
`stranded oligonucleotides
`
`is provided on a
`
`solid support;
`
`the
`
`oligonucleotides comprising a 5° end sequence region, a 3° end sequence region and at least two
`
`different sequences regions (N-1) and (N-2) between the 5’ end and the 3’ end sequence regions.
`
`An input polynucleotide, the input polynucleotide being a product of at least two cycles (N-2)
`
`and (N-1) of chain extension reaction is provided. The input polynucleotide is hybridized to the
`
`plurality of support-boundoligonucleotides, thereby forming duplexes in which the 3’ end of the
`
`input polynucleotide hybridizes to the (N-1) and (N-2) sequences regions of the support-bound
`
`oligonucleotide.
`
`In some embodiments, the duplexes comprise duplexes having at least one
`
`mismatch in a complementary region and duplexes that do not comprise a mismatch in the
`
`complementary region. The duplexes having at least one mismatch in the complementary region
`
`are denatured. under stringent melt conditions releasing error-containing input polynucleotides.
`
`In some embodiment,
`
`the support-bound oligonucleotides comprise at
`
`least three different
`
`sequences regions (N-1), (N-2) and (N-3) between the 5’ end and the 3’ end sequenceregions,
`
`and the input polynucleotide hybridizes to the (N-1), (N-2) and (N-3) sequences regions of the
`
`-6-
`
`

`

`WO 2011/085075
`
`PCT/US2011/020335
`
`support-bound oligonucleotides.
`
`In some embodiments,
`
`the 3’ end sequence is a spacer
`
`sequence and may comprise a primerbindingsite.
`
`[0014] In some embodiments, the (N-1) sequence is adjacent to the 5’ end sequence region and
`
`the (N-2) sequence region is adjacent to the (N-1) sequence region and so on.
`
`In some
`
`embodiments, each input polynucleotide is the product of a chain extension reaction. For
`
`example, the input polynucleotide may be the productof at least one, at least two, at least three,
`
`ctc.. extension chain reactions, cach extension chain reaction using a different plurality of
`
`support-boundoligonucleotides as a template. In some embodiments, the input polynucleotideis
`
`the product of at least two extension chain reactions, each extension chain reaction adding a
`
`sequenceat the 3’ end of the input polynucleotide. For example, a first extension chain reaction
`
`results in the addition of a first sequence complementary to sequence 1, the (n-2) extension
`
`reaction results in the addition of a sequence complementary to sequence (N-2),
`
`the (n-1)
`
`extension reaction results in the addition of a sequence complementary to sequence (N-1) and so
`
`on.
`
`[0015] In some embodiments, the extension duplexes are subjected to shuffling process before
`
`undergoing a next cycle of extension. The shuffling process comprises the steps of denaturing
`
`extension duplexes such as single-stranded extension products are released into solution; re-
`
`annealing single-stranded extension products to the support-bound oligonucleotides thereby
`
`producing re-annealed duplexes; subjecting the re-annealed duplexes to stringent melt conditions
`
`to dissociate error-containing duplexes; removing error-containing single-stranded extension
`
`products; and dissociating the error-free duplexes thereby releasing error-free extension products
`
`in solution.
`
`[0016] In some embodiments, each plurality of oligonucleotides is designed to serve as a
`
`template to a different polymerase extension reaction, thereby forming pluralities of extension
`
`duplexes, wherein each plurality of extension duplexes has a substantially identical melting
`
`temperature. In some embodiments, the difference of melting temperature between the plurality
`
`of duplexes is less than 10°C, less than 5°C, less than 1°C.
`
`[0017] In some aspects, methods for producing at least one double-stranded polynucleotide
`
`having a predefined sequence are provided.
`
`In some embodiments,
`
`in a first step, a
`
`polynucleotide is synthesized on a discrete feature of a support. The polynucleotide comprises a
`
`3’ terminal sequence region complementary to a 5’ region of an oligonucleotide at a discrete
`
`-7-
`
`

`

`WO 2011/085075
`
`PCT/US2011/020335
`
`feature and a 5’ terminal region that is not complementaryto the oligonucleotide. Atleast a first
`
`plurality of support-bound oligonucleotides is provided, wherein the at least first plurality of
`
`oligonucleotides has a predefined sequence and is boundtoafirst discrete feature of the support,
`
`each first plurality of oligonucleotides comprising a primer binding sequenceat its 3’ end and a
`
`sequence region at its 5’ end substantially identical to a 5’ end of the polynucleotide.
`
`In a
`
`subsequent step, the primer is annealed to the first plurality of oligonucleotides at the first
`
`discrete feature, wherein the anncaling of the primer to the first plurality of support-bound
`
`oligonucleotides serves as a primer for extension of the first plurality of complementary
`
`oligonucleotides,
`
`thereby generating a first extension product duplex. The primer is then
`
`removed from the extension duplex. Preferably, the primer sequence comprises at least one
`
`Uracil and the primer is removed using a mixture of Uracil DNA glycosylase (UDG) and the
`
`DNA glycosylase-lyase Endonuclease VIII. The first extension product duplex is dissociated
`
`thereby producinga first plurality of complementary oligonucleotides which are then transferred
`
`to a the discrete feature comprising the polynucleotide thereby bringing into contact the first
`
`plurality of oligonucleotides with the polynucleotide, wherein the
`
`first plurality of
`
`oligonucleotides is complementary to the 5’ end of the polynucleotide. The first plurality of
`
`complementary oligonucleotides is then annealed to the polynucleotide, wherein the annealing of
`
`the oligonucleotides serves as a primer for extension of the polynucleotide, thereby producing a
`
`double stranded polynucleotide.
`
`[0018] In some embodiments,
`
`the method for producing at
`
`least one double-stranded
`
`polynucleotide having a predefined sequence comprises the following steps: a) providingat least
`
`a first, a second and a third plurality of support-bound single-stranded oligonucleotides, each
`
`first, second and third plurality of oligonucleotides having a predefined sequence and being
`
`bound to a discrete feature of the support. Each first and second plurality of oligonucleotides
`
`comprise a primer bindingsite at its 3’ end that is complementary to a primer sequence and the
`
`first plurality of oligonucleotide has a sequence 5’ sequence region that is complementary to the
`
`5’ sequence region of the secondplurality of oligonucleotides and a sequence region between the
`
`primer binding site and the 5’ sequence region that is identical to a 5’ end of the third plurality of
`
`oligonucleotides, and the secondplurality of oligonucleotides comprises a primer bindingsite at
`
`its 3° end; b) annealing the primers to the primer binding sites of the first and the second
`
`plurality of oligonucleotides, wherein the annealing of the primerto the first and second plurality
`
`-8-
`
`

`

`WO 2011/085075
`
`PCT/US2011/020335
`
`of support-bound oligonucleotides serves as a primer for extension of the first and second
`
`plurality of complementary oligonucleotides, thereby producing a first and second plurality of
`
`extension product duplexes; c) removing the primer sequences from the extension product
`
`duplexes; d) dissociating the extension product duplexes, thereby producinga first and second
`
`plurality of complementary oligonucleotides; e) hybridizing the first plurality of complementary
`
`oligonucleotides to the third plurality of oligonucleotides; and f) hybridizing the second plurality
`
`of complementary oligonucleotides to the first plurality of oligonuclcotides, thereby producing
`
`the polynucleotide.
`
`In some embodiments, the method further provides a fourth plurality of
`
`support-boundsingle-stranded oligonucleotides wherein each fourth plurality of oligonucleotides
`
`has a predefined sequence and is bound to a fourth discrete feature of the support, each fourth
`
`plurality of oligonucleotides comprising a primer binding site at its 3’ end that is complementary
`
`to a primer sequence and a sequence region that
`
`is complementary to a 5° end of the
`
`polynucleotide, and repeating steps b) through f) thereby producing a longer polynucleotide.
`
`In
`
`some embodiments, the primers hybridizing to the first and second plurality of oligonucleotides
`
`are the same. The primers may comprise at least one Uracil and the primer is removed using a
`
`mixture of Uracil DNA glycosylase (UDG) and the DNA glycosylase-lyase Endonuclease VIII.
`
`[0019] In some embodiments,
`
`the method for producing at
`
`least one double-stranded
`
`polynucleotide having a predefined sequence comprises the following steps: a) providingat least
`
`a first and a second plurality of support-bound single-stranded oligonucleotides, each first and
`
`secondplurality of oligonucleotides having a predefined sequence and being boundtoafirst and
`
`second discrete feature of the support, each first plurality of oligonucleotides comprising a
`
`primer binding site at its 3’ end which is complementary to a primer sequence, a first sequence
`
`region at the 5’ end of the primer bindingsite and a second 3’ end sequence region and wherein
`
`the second plurality of oligonucleotides comprises a sequence region at its 5’ end thatis identical
`
`to the first sequence region of the first plurality of oligonucleotides; b) annealing the primer to
`
`the primer binding sites of the first plurality of oligonucleotides at the first feature, wherein the
`
`annealing of the primer to the first plurality of support-bound oligonucleotides serves as a primer
`
`for extension of the first plurality of complementary oligonucleotides, thereby producing a first
`
`plurality of extension product duplexes; c) removing the primer sequences from the extension
`
`
`
`product duplexes; d) dissociating the extension product duplexes, thereby producingafirst
`
`plurality of complementary oligonucleotides; e) hybridizing the first plurality of complementary
`
`-9.
`
`

`

`WO 2011/085075
`
`PCT/US2011/020335
`
`oligonucleotides to the second plurality of oligonucleotides at the second feature;
`
`f) providing a
`
`stem-loop oligonucleotide, wherein the 3’ end of the stem structure is complementary to the 3’
`
`end of the extension product; g) hybridizing the stem-loop oligonucleotide to the first plurality
`
`of oligonucleotides at the second feature; and h) ligating the stem-loop oligonucleotide to the
`
`first extension product, thereby generating the double-stranded stem and loop polynucleotide. In
`
`some embodiments, the method further comprises a) providing at least a third and a fourth
`
`plurality of support-bound single-stranded oligonucleotides, cach third and fourth plurality of
`
`oligonucleotides having a predefined sequence and being boundto a third and fourth discrete
`
`feature of the support, each third plurality of oligonucleotides comprising a primer bindingsite at
`
`its 3’ end which is complementary to a primer sequence,a first sequence region at the 5’ end of
`
`the primer binding site, the first region sequence being substantially identical to the S’ end of the
`
`double-stranded stem-loop polynucleotide and a second 3° end sequence region, wherein the
`
`fourth plurality of oligonucleotides comprises a sequence region at
`
`its 5’ end which is
`
`substantially identical to the first sequence region ofthe third plurality of oligonucleotides; b)
`
`annealing the primer to the primer binding sites of the third plurality of oligonucleotides at the
`
`third feature, wherein the annealing of the primer to the third plurality of support-bound
`
`oligonucleotides serves as a primer for extension of the third plurality of complementary
`
`oligonucleotides, thereby producing a third plurality of extension product duplexes; c) removing
`
`the primer sequences from the extension product duplexes; d) dissociating the extension product
`
`duplexes, thereby producinga third plurality of complementary oligonucleotides; e) hybridizing
`
`the third plurality of complementary oligonucleotides to the fourth plurality of oligonucleotides
`
`at the fourth feature; f) dissociating the double-stranded stem-loop polynucleotide from the
`
`second feature; g) transferring the stem-loop polynucleotide to the fourth feature; h) hybridizing
`
`the stem-loop polynucleotide to the fourth plurality of oligonucleotides at the fourth feature,
`
`thereby extending the stem-loop polynucleotide; and h) ligating the 3’ end of the stem-loop
`
`polynucleotide with the 5’ end of the third plurality of oligonucleotides, thereby forming a longer
`
`double-stranded polynucleotide.
`
`In some embodiments, steps a) through h) may berepeated to
`
`produce a longer polynucleotide.
`
`In some embodiments, the primers hybridizingto the first and
`
`second plurality of oligonucleotides are the same. The primers may comprise at least one Uracil
`
`and the primer is removed using a mixture of Uracil DNA glycosylase (UDG) and the DNA
`
`glycosylase-lyase Endonuclease VIII.
`
`-10-
`
`

`

`WO 2011/085075
`
`PCT/US2011/020335
`
`[0020]
`
`In some embodiments,
`
`the method for producing at
`
`least one double-stranded
`
`polynucleotide having a predefined sequence comprises a) synthesizing a polynucleotide at a
`
`first discrete feature; b) synthesizing a complementary oligonucleotide at a second discrete
`
`feature, wherein the 3’ terminal region of the complementary oligonucleotide is complementary
`
`to the
`
`5’
`
`terminal
`
`region of the polynucleotide;
`
`cc)
`
`transferring the complementary
`
`oligonucleotide to the first feature; and d) hybridizing the complementary oligonucleotide to the
`
`polynucleotide.
`
`BRIEF DESCRIPTION OF THE FIGURES
`
`[0021] Fig. 1 illustrates an exemplary method of for the elongation of polynucleotides on a solid
`
`support using repeated polymerase extension reactions.
`
`[0022] Fig. 2 illustrates a non-limiting example screening of extension junctions formed during
`
`the (n-1) and (n-2) extensionssteps.
`
`[0023] Tig. 3 illustrates a non-limiting example of different design strategies of screening of
`
`error-containing polynucleotides.
`
`[0024] Fig. 4 illustrates a non-limiting exemplary method for polynucleotide extension and
`
`screening of error-containing polynucleotides.
`
`[0025] Fig. 5 illustrates a non-limiting ex

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.

We are unable to display this document.

PTO Denying Access

Refresh this Document
Go to the Docket